The DOI matches its Crossref record.
4β‐hydroxycholesterol, an endogenous marker of CYP3A4/5 activity in humans
Open accessAbstract
We have proposed that 4β‐hydroxycholesterol (4β‐OHC) may be used as an endogenous marker of CYP3A activity. The cholesterol metabolite 4β‐OHC is formed by CYP3A4. Treatment of patients with strong inducers of CYP3A enzymes, e.g. anti‐epileptic drugs, resulted in 10‐fold increased concentrations of plasma 4β‐OHC, while treatment with CYP3A inhibitors such as ritonavir or itraconazole resulted in decreased plasma concentrations. There was a relationship between the 4β‐OHC concentration and the number of active CYP3A5*1 alleles showing that 4β‐OHC was not only formed by CYP3A4, but also by CYP3A5. The concentration of 4β‐OHC was higher in women than in men, confirming previous studies indicating a gender difference in CYP3A4/5‐activity. The rate of elimination of 4β‐OHC is slow (half‐life 17 days) which results in stable plasma concentrations within individuals, but limits its use to study rapid changes in CYP3A activity. In short‐term studies exogenous markers such as midazolam or quinine may be superior, but in long‐term studies 4β‐OHC is a sensitive marker of CYP3A activity, especially to assess induction but also inhibition. Under conditions where the cholesterol concentration is changing, the ratio of 4β‐OHC : cholesterol may be used as an alternative to 4β‐OHC itself. The use of an endogenous CYP3A marker has obvious advantages and may be of value both during drug development and for monitoring CYP3A activity in patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Zanger, U. M., & Schwab, M. (2013) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2012.12.007 · Cited by 4,169
“00001) by measuring the proposed endogenous CYP3A4/5 metabolite-marker 4β-hydroxycholesterol (Diczfalusy et al., 2011).”
BackgroundCobbina, E., & Akhlaghi, F. (2017) · Drug Metabolism Reviews · doi:10.1080/03602532.2017.1293683 · Cited by 653
Marques, L., Costa, B., Pereira, M., Silva, A., Santos, J., Saldanha, L., Silva, I., Magalhães, P., Schmidt, S., & Vale, N. (2024) · Pharmaceutics · doi:10.3390/pharmaceutics16030332 · Cited by 390
Honda, A., Ikegami, T., Nakamuta, M., Miyazaki, T., Iwamoto, J., Hirayama, T., Saito, Y., Takikawa, H., Imawari, M., & Matsuzaki, Y. (2013) · Hepatology · doi:10.1002/hep.26018 · Cited by 210
DeGorter, M. K., Tirona, R. G., Schwarz, U. I., Choi, Y.-H., Dresser, G. K., Suskin, N., Myers, K., Zou, G., Iwuchukwu, O., Wei, W.-Q., et al. (2013) · Circulation: Cardiovascular Genetics · doi:10.1161/circgenetics.113.000099 · Cited by 195
Metadata
- Authors
- Diczfalusy, U., Nylén, H., Elander, P., & Bertilsson, L.
- Venue
- British Journal of Clinical Pharmacology
- Publisher
- Wiley
- Published
- 2011-01-10
- Volume
- 71
- Issue
- 2
- Pages
- 183-189
- ISSN
- 0306-5251 (ISSN-L)
- 1365-2125
- OpenAlex
- W1593954768
- Cited by
- 202
- References
- 0
- FWCI
- 8.93
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: 4β‐hydroxycholesterol, an endogenous marker of CYP3A4/5 activity in humans. https://app.cochat.ai/papers/10.1111/j.1365-2125.2010.03773.x
- The paper
- Diczfalusy, U., Nylén, H., Elander, P., & Bertilsson, L. (2011). 4β‐hydroxycholesterol, an endogenous marker of CYP3A4/5 activity in humans. British Journal of Clinical Pharmacology. https://doi.org/10.1111/j.1365-2125.2010.03773.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.